Skip to content
GenoLensGenoLens

SOX17

Chr 8q11.23

SRY-box transcription factor 17

MANE:
ENST00000297316.5

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Pulmonary arterial hypertension

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • CAKUT

  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Unexplained kidney failure in young people

  • Unexplained young onset end-stage renal disease - additional genes

    Unknown

Disease associations (Open Targets)

  • familial vesicoureteral reflux

    0.64
  • vesicoureteral reflux 3

    0.59
  • pulmonary arterial hypertension

    0.49
  • heritable pulmonary arterial hypertension

    0.47
  • endometrial cancer

    0.39
  • vesicoureteral reflux

    0.37
  • hereditary disease

    0.34
  • brain aneurysm

    0.32
  • pulmonary hypertension, primary, 7

    0.30
  • digestive system disorder

    0.28

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Transcription factor SOX-17

Acts as a transcription regulator that binds target promoter DNA (PubMed:33952808). Binds to the sequences 5'-AACAAT-'3 or 5'-AACAAAG-3'. Modulates transcriptional regulation via WNT3A. Inhibits Wnt signaling. Promotes degradation of activated CTNNB1. Plays a key role in the regulation of embryonic development. Required for normal development of the definitive gut endoderm. Required for normal looping of the embryonic heart tube. Plays an important role in embryonic and postnatal vascular development, including development of arteries. Plays an important role in postnatal angiogenesis, where it is functionally redundant with SOX18. Required for the generation and maintenance of fetal hematopoietic stem cells, and for fetal hematopoiesis. Probable transcriptional activator in the premeiotic germ cells

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.